Armune Bio’s Cancer Detection Tech Finds New Home with Exact Sciences
166834
post-template-default,single,single-post,postid-166834,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Armune Bio’s Cancer Detection Tech Finds New Home with Exact Sciences

Armune BioScience

Armune Bio’s Cancer Detection Tech Finds New Home with Exact Sciences

The annual J.P. Morgan Healthcare Conference, held earlier this month in San Francisco, is a popular venue for biotech companies to announce new deals and milestones achieved.

One such announcement from this year’s event has largely flown under the radar: Madison, WI-based molecular diagnostics company Exact Sciences acquired Armune BioScience, a cancer diagnostic startup with offices in Kalamazoo and Ann Arbor, MI. The terms of the deal were not disclosed.

READ FULL ARTICLE